BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15500448)

  • 1. Depletion of Caco-2 cell cholesterol disrupts barrier function by altering the detergent solubility and distribution of specific tight-junction proteins.
    Lambert D; O'Neill CA; Padfield PJ
    Biochem J; 2005 Apr; 387(Pt 2):553-60. PubMed ID: 15500448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Displacement of tight junction proteins from detergent-resistant membrane domains by treatment with sodium caprate.
    Sugibayashi K; Onuki Y; Takayama K
    Eur J Pharm Sci; 2009 Feb; 36(2-3):246-53. PubMed ID: 19013238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol depletion alters detergent-specific solubility profiles of selected tight junction proteins and the phosphorylation of occludin.
    Lynch RD; Francis SA; McCarthy KM; Casas E; Thiele C; Schneeberger EE
    Exp Cell Res; 2007 Jul; 313(12):2597-610. PubMed ID: 17574235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl-beta-cyclodextrin increases permeability of Caco-2 cell monolayers by displacing specific claudins from cholesterol rich domains associated with tight junctions.
    Lambert D; O'Neill CA; Padfield PJ
    Cell Physiol Biochem; 2007; 20(5):495-506. PubMed ID: 17762176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GLP-2 enhances barrier formation and attenuates TNFα-induced changes in a Caco-2 cell model of the intestinal barrier.
    Moran GW; O'Neill C; McLaughlin JT
    Regul Pept; 2012 Oct; 178(1-3):95-101. PubMed ID: 22809889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaempferol enhances intestinal barrier function through the cytoskeletal association and expression of tight junction proteins in Caco-2 cells.
    Suzuki T; Tanabe S; Hara H
    J Nutr; 2011 Jan; 141(1):87-94. PubMed ID: 21068182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-18 facilitates neutrophil transmigration via myosin light chain kinase-dependent disruption of occludin, without altering epithelial permeability.
    Lapointe TK; Buret AG
    Am J Physiol Gastrointest Liver Physiol; 2012 Feb; 302(3):G343-51. PubMed ID: 22135309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol efflux stimulates metalloproteinase-mediated cleavage of occludin and release of extracellular membrane particles containing its C-terminal fragments.
    Casas E; Barron C; Francis SA; McCormack JM; McCarthy KM; Schneeberger EE; Lynch RD
    Exp Cell Res; 2010 Feb; 316(3):353-65. PubMed ID: 19854171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of claudin-5 to barrier properties in tight junctions of epithelial cells.
    Amasheh S; Schmidt T; Mahn M; Florian P; Mankertz J; Tavalali S; Gitter AH; Schulzke JD; Fromm M
    Cell Tissue Res; 2005 Jul; 321(1):89-96. PubMed ID: 16158492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular zinc is required for intestinal epithelial barrier maintenance via the regulation of claudin-3 and occludin expression.
    Miyoshi Y; Tanabe S; Suzuki T
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G105-16. PubMed ID: 27151944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells.
    Noda S; Tanabe S; Suzuki T
    Mol Nutr Food Res; 2013 Nov; 57(11):2019-28. PubMed ID: 23868418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of ZO-1, occludin, and actin in oxidant-induced barrier disruption.
    Musch MW; Walsh-Reitz MM; Chang EB
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G222-31. PubMed ID: 16239402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid reduction of MDCK cell cholesterol by methyl-beta-cyclodextrin alters steady state transepithelial electrical resistance.
    Francis SA; Kelly JM; McCormack J; Rogers RA; Lai J; Schneeberger EE; Lynch RD
    Eur J Cell Biol; 1999 Jul; 78(7):473-84. PubMed ID: 10472800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers.
    Doi N; Tomita M; Hayashi M
    Drug Metab Pharmacokinet; 2011; 26(2):162-70. PubMed ID: 21206134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yogurt inhibits intestinal barrier dysfunction in Caco-2 cells by increasing tight junctions.
    Putt KK; Pei R; White HM; Bolling BW
    Food Funct; 2017 Jan; 8(1):406-414. PubMed ID: 28091645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan enhances intestinal barrier function by upregulating the expression of claudin-1.
    Iraha A; Chinen H; Hokama A; Yonashiro T; Kinjo T; Kishimoto K; Nakamoto M; Hirata T; Kinjo N; Higa F; Tateyama M; Kinjo F; Fujita J
    World J Gastroenterol; 2013 Sep; 19(33):5500-7. PubMed ID: 24023493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia/reoxygenation injury.
    Jin Y; Blikslager AT
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C996-C1004. PubMed ID: 27760753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conditioned medium from LS 174T goblet cells treated with oxyresveratrol strengthens tight junctions in Caco-2 cells.
    Hwang D; Jo H; Hwang S; Kim JK; Kim IH; Lim YH
    Biomed Pharmacother; 2017 Jan; 85():280-286. PubMed ID: 27876210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of NKCC1 function increases epithelial tight junction permeability by upregulating claudin-2 expression.
    Koumangoye R; Penny P; Delpire E
    Am J Physiol Cell Physiol; 2022 Oct; 323(4):C1251-C1263. PubMed ID: 35968893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF-1 decreases portal vein endotoxin via regulating intestinal tight junctions and plays a role in attenuating portal hypertension of cirrhotic rats.
    Zhao TY; Su LP; Ma CY; Zhai XH; Duan ZJ; Zhu Y; Zhao G; Li CY; Wang LX; Yang D
    BMC Gastroenterol; 2015 Jul; 15():77. PubMed ID: 26152281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.